Dachaigh › Luchd-obrach › Somite Therapeutics
Somite Therapeutics: Tuarastalan H-1B agus taic bhìosa
Chuir Somite Therapeutics 14 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 14. Tuarastal meadhanach a chaidh a thabhann: $127,500.
A bheil Somite Therapeutics a’ toirt taic do bhìosaichean H-1B?
Chuir Somite Therapeutics 14 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 4 Cèit 2026. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Senior Process Engineer | 2 | $113,604 |
| Senior Scientist | 2 | $140,000 |
| Principal Scientist, Biology | 2 | $155,000 |
| Senior Research Associate, Translational Science | 2 | $109,500 |
| AI Data Scientist | 1 | $112,629 |
| Senior Cell Scientist | 1 | $115,000 |
| Staff Software Engineer | 1 | $250,000 |
| ML Research Scientist | 1 | $130,000 |
| Scientist, Translational Science | 1 | $125,000 |
| Entrepreneur-in-Residence/Chief of Staff | 1 | $230,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2024 | 2 | $107,418 |
| FY2025 | 5 | $135,000 |
| FY2026 | 7 | $125,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Molecular and Cellular Biologists10
- Data Scientists1
- Software Developers1
- Computer and Information Research Scientists1
- Project Management Specialists1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Entrepreneur-in-Residence/Chief of Staff | $230,000 Ìre IV | Brooklyn, NY | 4 Cèit 2026 | 18 Cèit 2026 | Dearbhaichte |
| Principal Scientist, Biology | $155,000 Ìre IV | Boston, MA | 16 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Senior Process Engineer | $125,000 Ìre III | Boston, MA | 13 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Scientist, Translational Science | $125,000 Ìre III | Boston, MA | 13 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Principal Scientist, Biology | $155,000 Ìre IV | Boston, MA | 13 Gibl 2026 | 13 Lùna 2026 | Dearbhaichte |
| Senior Research Associate, Translational Science | $114,000 Ìre III | Boston, MA | 13 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Senior Research Associate, Translational Science | $105,000 Ìre II | Boston, MA | 13 Gibl 2026 | 1 Dàmh 2026 | Dearbhaichte |
| Senior Scientist | $135,000 Ìre IV | Boston, MA | 22 Cèit 2025 | 23 Ògmh 2025 | Dearbhaichte |
| ML Research Scientist | $130,000 Ìre I | Boston, MA | 13 Cèit 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Staff Software Engineer | $250,000 Ìre IV | Boston, MA | 13 Cèit 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Senior Scientist | $145,000 Ìre IV | Boston, MA | 30 Gibl 2025 | 1 Dàmh 2025 | Dearbhaichte |
| Senior Cell Scientist | $115,000 Ìre III | Boston, MA | 27 Sult 2024 | 7 Dàmh 2024 | Dearbhaichte |
| AI Data Scientist | $112,629 Ìre II | Boston, MA | 13 Lùna 2024 | 4 Sult 2024 | Dearbhaichte |
| Senior Process Engineer | $102,208 Ìre II | Boston, MA | 18 Ògmh 2024 | 1 Iuch 2024 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).